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Abstract
Mammalian liver disposes of acetaminophen and other ingested xenobiotics by forming soluble glucuronides that are subse-
quently removed via renal filtration. When given in combination with the stable isotopes 2H and 13C, the glucuronide of acet-
aminophen isolated from urine provides a convenient ‘‘chemical biopsy’’ for evaluating intermediary metabolism in the liver. Here,
we describe isolation and purification of urinary acetaminophen glucuronide and its conversion to monoacetone glucose (MAG).
Subsequent 2H and 13C NMR analysis of MAG from normal volunteers after ingestion of 2H2O and [U-
13C3]propionate allowed a
noninvasive profiling of hepatic gluconeogenic pathways. The method should find use in metabolic studies of infants and other
populations where blood sampling is either limited or problematic.
 2003 Elsevier Science (USA). All rights reserved.
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Assessment of fluxes through the central metabolic
pathways of human hepatic glucose production is
essential to the understanding of pathogenesis and the
consequences of therapy in several major diseases,
including type II diabetes and cirrhosis. In humans, these
fluxes are typically evaluated by administration of pre-
cursors enriched with 2H or 13C in conjunction with mass
spectroscopy or NMR analysis of plasma glucose. For
example, Landau and co-workers have shown, following
the oral administration of 2H2O, that the
2H-enrichment
distribution of glucose provides a direct measure of the
contributions of glycogenolysis and gluconeogenesis to
glucose production [1,2]. This technique has attracted
considerable interest because of the rapid increase in
incidence of type II diabetes in human populations.
Similarly, oral or intravenous administration of a
gluconeogenic 13C tracer, such as [U-13C3]propionate,
can provide metabolic flux information at the level of the
hepatic citric acid cycle, the major source of gluconeo-
genic carbons and a key regulatory site for gluconeo-
genesis [3–7]. We recently demonstrated that NMR
analysis of plasma glucose enriched with a combination
of 2H and 13C tracers provides a comprehensive picture
of glycogenolysis, gluconeogenesis, and citric acid cycle
flux in humans [6].
In the aforementioned human studies, 20–30ml of
blood was required for high-quality NMR spectra [4,6].
This quantity of blood may prove prohibitive for the
evaluation of metabolism in neonates, children, elderly,
or patients with infectious blood such as in HIV or
hepatitis. An alternative method for sampling the
plasma glucose pool is to perform a ‘‘chemical biopsy’’
using acetaminophen [8,9]. After a single therapeutic
dose (10–12mg/kg), acetaminophen is metabolized in
the liver by microsomal enzymes to acetaminophen-
glucuronide (60%), acetaminophen-sulfate (35%),
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acetaminophen-cysteine (3%), and a residual percent-
age oxidized by cytochrome P450 enzymes [10]. Acet-
aminophen glucuronide (AG)1 is formed by
condensation of acetaminophen with UDP-glucose
(UDPG). The glucose moiety of UDPG is derived
from hepatic glucose 1-phosphate, which is in rapid
exchange with glucose 6-phosphate, the direct precur-
sor of intrahepatic glucose.
After purification, 300–900 lmol of AG can be sam-
pled from urine of a normal adult, about 4–12 times the
amount of glucose recovered from a 30-ml blood sam-
ple. In a previous report, we demonstrated that the 13C-
isotopomer data could be obtained by 13C NMR after
conversion of urinary AG to glucuronic acid [4]. How-
ever, proton chemical-shift dispersion of this product is
inadequate for resolving and quantifying 2H enrichment
in all positions by 2H NMR. Given that the 1,2-di-
isopropylidene glucofuranose (MAG) derivative of glu-
cose offers excellent chemical-shift dispersion for both
2H [6] and 13C NMR analyses, we focused on the
chemical conversion of AG to MAG. Although a few
literature accounts of conversion of AG to glucose exist
[8,11,12], there are no reports of successful conversion of
AG to MAG. The method presented here provides
sufficient MAG for NMR studies, is spectroscopically
clean, and gives good chemical-shift dispersion of all 1H,
2H, and 13C signals.
Methods
Materials
[U-13C3]propionate (99%) and
2H2O (70%) were
purchased from Cambridge Isotopes (Andover, MA).
Acetaminophen (1000mg tablets) was purchased from a
local pharmacy. DSC-18 solid-phase extraction (SPE)
gel was obtained from Supelco (St. Louis, MO). Other
common chemicals were obtained from Sigma (St.
Louis, MO) unless otherwise noted.
Tracer and acetaminophen administration
All samples were obtained from normal adult vol-
unteers who provided informed consent prior to the
study. The protocol was approved by the institutional
review board (IRB) at the Dallas Veterans Affairs
Medical Center prior to patient enrollment. Five indi-
viduals were studied. Following an early evening meal,
subjects fasted overnight prior to the study. They re-
ported to the Clinical Research Unit between 0700 and
0800. Over the first hour, the tracers were given orally in
three divided doses. All subjects received a total of 5 g/
kg body water deuterium oxide and 10mg/kg body
weight of [U-13C]propionate. With the first dose of
tracers, the patients also received 1000mg of acetami-
nophen. Then 20–30ml of blood was drawn at 2, 3, and
4 h following ingestion of the final tracer dose. At 4 h,
the subjects also voided their bladders with all urine
being retained for NMR analysis.
Acetaminophen-glucuronide isolation
The amount of 100–300ml of urine was collected
from patients and immediately sterilized by treatment
with 50ml of acetone for 2 h [13]. The pH of the urine
was then adjusted to pH 4.5 with 70% perchloric acid
and the volume was reduced by 50% using rotary
evaporation at 50 C and 30mm Hg. This solution was
diluted to its original volume with water and treated
with 10,000U of urease. The pH of the sample was
maintained near 7 by adding drops of 70% perchloric
acid every 30–60min as necessary. Finally, the pH was
reduced to 4.5, the solution was filtered, lyophilized to
dryness, and refrigerated until further use.
Acidic water (pH 2.5) was prepared by adding 1 ml of
concentrated phosphoric acid to 700ml of deionized
water. Thirty grams of SPE gel was loaded into a 60ml
syringe and treated with 50ml of 100% methanol fol-
lowed by 100ml of acidic water. The freeze-dried, urea-
free, urine sample was dissolved in a minimum amount
of water (typically 3–10ml) and the pH was adjusted to
2–2.5. The sample was loaded onto the column and
washed with 120ml of acidic water, 120ml of 10%
methanol in acidic water, and finally 120ml of 100%
methanol. The 10% methanol washing was collected, the
pH was adjusted to 7, and the solvent was removed
under vacuum to give a light-colored solid. This repre-
sented 70–88% of total urinary glucuronide as measured
by HPLC.
Conversion of AG to MAG
Acetaminophen-glucuronide methyl ester. The purified
urinary AG was dissolved in 50ml of dry methanol,
300 ll of BF3 was added dropwise, and the mixture was
stirred overnight at room temperature. Typically, HPLC
analyses indicated 90–98% conversion to the ester.
Whenever HPLC showed lower amounts of ester for-
mation, those samples were once again freeze-dried and
the reaction was repeated.
Acetaminophen-glucoside. Following conversion to
the ester, 1200mg of NaBH4 was added (in 60mg por-
tions over 3 h) to the same reaction flask. The reduction,
as indicated by either HPLC or 1H NMR, was typically
89–98% complete. If glucoside formation was less than
90%, additional 60mg portions of NaBH4 were added
1 Abbreviations used: AG, acetaminophen glucuronide; UDPG,
UDP-glucose; MAG, 1,2-diisopropylidene glucofuranose; SPE, solid-
phase extraction; HPLC, high-performance liquid chromatography;
LFP, liver flux profile.
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until conversion reached the desired level. The pH of the
solution was adjusted to 2 with concentrated HCl and
the solvent was removed under vacuum to give a brown
residue. The residue was washed 3 2ml of methanol
and any remaining salt was removed by filtration. The
washes were combined and evaporated.
Glucose. The glucoside was dissolved in 25ml of water,
and the pH was adjusted to 7.4 and stirred overnight with
10,000U of b-glucosidase. This solution was lyophilized
and redissolved in aminimal amount ofwater and applied
to a 5-g SPE column, prepared as described above. The
glucose was eluted with 40ml of water leaving colored
impurities behind. The colorless washwas lyophilized to a
white solid consisting of 40–60mg of glucose (by enzy-
matic assay) and 200mg of salt.
1,2-Isopropylidene glucofuranose. MAG was synthe-
sized using slight modifications of a previously reported
procedure [2]. The glucose/salt solid was pulverized and
suspended in 10ml of dry acetone. Four hundred micro-
liters of concentrated H2SO4 was added and the mix was
stirred for 8 h at room temperature. Ten milliliters of
water was added and the pHwas adjusted to 2.0 with 5M
Na2CO3. This solution was stirred for another 24 h or
until completion as indicated by 1H NMR. The pH was
adjusted to 8.0with 5MNa2CO3 and the solvent removed
under vacuum. The resulting solid was washed with
5 3ml of boiling ethyl acetate. The washings were
combined and the solvent was removed under vacuum
leaving a yellow residue. A 5-g SPE cartridge was pre-
pared by washing with 20ml of methanol followed by
60ml of water. The residue was dissolved in 0.5ml of
water and applied to the SPE cartridge. The cartridge was
washed with one fraction of 20ml of water (to remove
impurities), 40ml of 10% methanol (to remove pure
MAG), and 20ml of methanol (to completely clean the
column).
Hydrogen exchange during synthesis
The synthetic steps described above were also run
using a commercial sample of AG (Sigma, St. Louis,
MO) in the presence of various deuterated solvents and
reactants to test for hydrogen exchange during the
synthesis of MAG. The following five conditions were
examined: (1) esterification and reduction reactions were
performed in 50% [U-2H4]methanol, (2) the reduction
reaction was performed with 98% sodium borodeute-
ride, (3) hydrolysis of AG by b-glucosidase was
performed in 50% 2H2O, (4) glucose was converted
to MAG in 50% [U-2H6]acetone, or (5) glucose was
converted to MAG using 2H2SO4.
NMR spectroscopy
NMR spectroscopy was performed as previously
reported [6]. Briefly, the samples were dissolved in
150 ll of acetonitrile and 10 ll of deuterium-depleted
water. More water was added when necessary to
completely dissolve the sample. 1H NMR spectroscopy
was performed on a 14.1 T Varian spectrometer using
a 3-mm Nalorac inverse detection probe for 1H de-
tection. Acquisition parameters included 90 pulse ex-
citation pulse, 1 s delay between pulses, 2 s acquisition
time, and 256 acquisitions. Deuterium NMR spectra
were collected using a Nalorac single-tuned deuterium
probe using the following parameters: 90 excitation
pulse, zero delay between pulses, 1 s acquisition time
and an average of 5000–10,000 acquisitions over 2–4 h.
Waltz-16 decoupling was used to remove proton–deu-
terium J coupling. Deuterium spectra were collected in
blocks of 256 acquisitions without lock followed by a
single pulse on the proton channel. The proton posi-
tion of the solvent peak was ascertained and Z0 was
automatically adjusted as a correction to any field drift
since the collection of the last block. At the end of
acquisition all blocks were summed for the final spec-
trum. Carbon-13 spectra were collected on the same
samples (after the addition of 20 ll of deuterated ace-
tonitrile for locking) using a 3-mm broadband probe
tuned to 150MHz using the following parameters: 45
excitation pulse, zero delay between pulses, and a 3 s
acquisition time provided fully relaxed carbon spectra.
A Waltz-16 sequence was used to decouple protons
from 13C.
High-performance liquid chromatography
High-performance liquid chromatography (HPLC)
of the urinary AG and other derivatives was performed
on a Dionex Summit HPLC system equipped with a
Vyadec C-18 column, a multichannel UV wavelength
detector set at 254 nm, and a automatic sampler set to
inject 5–20 ll of sample. The sample was eluted with 7%
acetonitrile in water with a trace of H2PO3 (0.72ml per
1L of water).
Analysis of 2H and 13C NMR spectra
Metabolic flux data were estimated from the NMR
spectra as previously reported [6,7]. The fractional
contribution of glycogen to endogenous glucose pro-
duction is calculated as 1 ðH5=H2Þ, where H5 and
H2 represent the 2H peak area at the 5 and 2 positions
of MAG, respectively. Carbon-13-isotopomer data
from the C2 of MAG yield relative metabolic fluxes,
with citrate synthase flux set to a value of 1.0. Relative
gluconeogenic output was calculated as ðC2Q
C2D23Þ=C2D23. Pyruvate cycling was calculated as
ðC2D12 C2QÞ=C2D23. Anaplerosis was calculated as
ðC2D12 C2D23Þ=C2D23, where C2Q, C2D12, and
C2D23 are the fractional contribution each multiplet
makes to the total C2 resonance.
230 S.C. Burgess et al. / Analytical Biochemistry 312 (2003) 228–234
Results
Urinary AG
AGwasmeasured in each urine sample byHPLC after
treatment with urease. The average content of AG was
150 75mg and subsequent purification by SPE gave a
70–88% yield. SPE purification was chosen because it has
been shown to be an effective method for purifying acet-
aminophen metabolites from urine samples [14]. Fig. 1
shows the 1H spectrum of the urine before and after pu-
rification of AG using a SPE column (HPLC tracings
shown as insets). Prior to purification, the 1H spectra
looked very similar to those reported in the literature [15].
Those spectra were also used to assign many of the reso-
nances in Fig. 1.After purification, themajority of the salt
and extraneous metabolites had been removed leaving
acetaminophen derivatives present as 10% acetamino-
phen-sulfate and 90% acetaminophen-glucuronide.
Conversion of AG to MAG
Fig. 2 shows a scheme of all of the synthetic steps
used to convert AG to MAG. The conversion of AG to
glucose was very good, with the greatest losses occurring
in the reduction step (89–98% yield). The total yield of
glucose from urinary glucuronide was 50–80%. Con-
version of the resulting glucose to MAG was monitored
by NMR and also gave a high yield (80%). Impurities
remaining in this reaction mixture were mainly unhy-
drolyzed diacetone glucose and some unidentified glu-
cose derivatives (likely, less favored isopropylidene
glucose derivatives). The overall yield from urinary
glucuronide to MAG was generally 40–80%, but varied
from sample to sample likely due to the inherent vari-
ability in the urine matrix.
NMR spectra and metabolic profiles
Fig. 3 shows the typical 2H NMR spectrum of
MAG derived from urinary AG compared to MAG-
derived plasma glucose from the same subject. The
greater amount of material derived from the urinary
glucuronide typically allowed NMR experiments to be
completed 3 to 10 times faster than with plasma
samples or in the same amount of time but with better
signal to noise ratios. An obvious difference between
the two spectra is the absence of the H6 deuterium
signals in the urine spectrum. This loss is a result of
the oxidation of C-6 during the in vivo synthesis of
AG. When unlabeled AG was derivatized using sol-
vents and reactants highly enriched with deuterium,
2H NMR analysis of the MAG product indicated that
it was not enriched above the natural abundance level
Fig. 1. (a) 1H NMR spectrum of the semipurified urine of a subject after ingesting 1000mg of acetaminophen. AC, acetaminophen cysteinyl; AG,
acetaminophen glucuronide; AS, acetaminophen sulfate. The inset is a HPLC tracing. (b) The same sample after purification by C-18 chroma-
tography. Only AG and a small amount of AS remain. (hippurate, Hipp; acetaminophen sulfate, AS; acetaminophen cysteinyl, AC; acetaminophen
N-acetyl-L-cysteinyl, NAC; glycine, Gly; trimethylamin-N-oxide, TMAO).
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in hydrogens 1–5. However, the hydrogen 6 positions
were predictably enriched with deuterium following
reduction in [U-2H4]methanol or with sodium boro-
deuteride.
For 5 normal volunteers after an overnight fast, the
fraction of glucose derived from glycogenolysis, as de-
termined from the ratio of H5 to H2 signal intensities
from the 2H spectra, was 51% 11. This matches the
value obtained from analysis of plasma glucose of
healthy subjects fasted for the same duration in a pre-
vious study [52% 7, Ref. 6].
Fig. 4 shows 13C spectra of MAG derived from uri-
nary AG and from plasma glucose of the same patient.
Again, the superior quality of the urine-derived MAG
spectra was easy to appreciate. The two sources con-
sistently gave identical isotopomer data and corre-
sponding flux data as a previous report where flux data
were derived from spectra of glucuronide or glucose [4].
Here, the 13C NMR spectra of MAG derived from
urinary AG report that gluconeogenesis is 2:44 0:59,
pyruvate cycling is 5:22 0:45, and anaplerosis is
7:66 0:80, all relative to a TCA cycle flux of 1. These
values compare very well to control patients from a
previous study based upon analysis of glucuronic acid
(gluconeogenic output¼ 1:85 0:31, pyruvate cycling¼
5:27 1:05, anaplerosis¼ 7:11 1:13) [6].
Fig. 4. 13C NMR spectra of the C2 region of MAG derived from both
urinary glucuronide (bottom) and plasma glucose (top).
Fig. 2. Reaction scheme.
Fig. 3. 2H NMR spectra of monoacetone glucose derived from both
urinary glucuronide (bottom) and plasma glucose (top). Note the ab-
sence of H6 signals in the urinary glucuronide spectrum.
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Discussion
Since the liver is fundamental to glucose homeostasis, a
simple assay for interrogatingmultiple pathways involved
in hepatic glucose production could be an important
clinical research tool.We describe a simple technique that
allows a minimally invasive study of disorders of glucose
homeostasis, such as fasting hyperglycemia in type II di-
abetes. We have previously shown that a liver flux profile
(LFP) can be obtained by using a combination of stable
isotope tracers andNMR [6]. Themethod is simple and is
only limited by the amount of tracer that can be safely
administered and sample availability. The technique de-
scribed herein represents a significant advancement for
general clinical implementation of a NMR-derived LFP,
as urine collection is noninvasive and does not require
large volume phlebotomy.
Urinary AG has been used as a surrogate of hepatic
glucose, but only in conjunction with carbon tracers
[8,9,11,12]. To our knowledge, there are no other reports
of the use of glucuronides for monitoring enrichment of
hepatic glucose from 2H2O. One limiting feature of the
2H NMR spectrum of AG is the poor chemical-shift
dispersion. As demonstrated here, conversion of AG to
MAG alleviates this problem and allows a direct mea-
sure of the 2H enrichment at each site in MAG.
The yield for the conversion of urinary AG to glucose
was 50–85%, generally higher than previously reported
values (40%) [8]. The broad range in yield seemed to
correlate with the amount ofAG in urine, with the highest
yields coming from urine samples that contained less than
100mg of AG. The use of larger SPE columns with higher
capacities would likely increase yields, but this was not
attempted.
Exchange studies were carried out to investigate whe-
ther or not deuterium enrichment is modified during the
multistep synthesis ofMAG fromAG.While not an issue
for 13C studies, protons could possibly exchange during
conversion and lead to erroneous results for the 2H
analysis. However, even in reactions using 50% deuter-
ated reagents and solvents (methanol, water, sodium
borohydride, acetone) no significant exchange was ob-
served. An exception was at the H6 position where 2H
labeling from d4-methanol and sodium borodeuteride
was observed. This result was expected since glucuronide
C6 is reduced by sodium borohydride in methanol during
the conversion of the glucuronide methyl ester to the
glucoside analog.
While C6 deuterium enrichment in plasma glucose is
indicative of glucose production originating in the TCA
cycle [2], no such information can be deduced fromMAG
derived from AG. Without this information, one cannot
distinguish gluconeogenesis from glycerol versus that
from the TCA cycle. Nevertheless, the contribution of
glycogen to glucose production can be obtained from
urinary AG and this has been shown to differ in humans
during a number of different pathological states including
diabetes [16–19], obesity [19], and cirrhosis [20]. Isolation
and conversion of AG to a readily analyzable NMR
sample in high yield and purity now offer the possibility of
taking these measurements in a much broader range of
patient populations.
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